SPY363.67+1.01 0.28%
DIA299.24+0.50 0.17%
IXIC12,205.85+111.44 0.92%

ADiTx Therapeutics Q3 EPS $(0.37) Down From $(0.28) YoY

ADiTx Therapeutics (NASDAQ:ADTX) reported quarterly losses of $(0.37) per share. This is a 32.14 percent decrease over losses of $(0.28) per share from the same period last year.

· 11/13/2020 08:15
ADiTx Therapeutics (NASDAQ:ADTX) reported quarterly losses of $(0.37) per share. This is a 32.14 percent decrease over losses of $(0.28) per share from the same period last year.